Abstract Conditionally replicating adenoviruses (CRAVs) are a group of recombinant human adenoviruses genetically engineered to replicate in selected tissues, such as tumors. These viruses could potentially offer significant medicinal benefits, since the restrictive replication of these viral vectors leads to the lysis of target cells without harm to the surrounding tissues. The in vitro propagation and amplification of the CRAV vectors often requires special host cells with deregulated growth control pathways. In order to develop an efficient cell culture process for the scaleable production of a CRAV vector, A549 cells, a human lung carcinoma cell line normally cultured in adherent culture, were adapted to suspension culture. CRAV production was demonstrated with the suspension-adapted A549 cells and a baseline production process was developed in shake flasks. The ability to scale-up virus production was confirmed in stirred tank bioreactors. Molecular characterization of the suspension-adapted A549 cells indicates no significant changes in cellular mechanisms related to adenovirus infection.
Introduction
Virus infection is the most efficient method for the delivery of genetic materials to target cells. Among the many different types of viral vectors utilized by researchers, adenovirus has the advantages of being easy to produce in large quantities at high titer, possessing the ability to infect non-dividing as well as dividing cells, having the capacity to accommodate large pieces of foreign DNA, and the non-integration nature of its genome. For these reasons, recombinant adenoviruses have been widely used in clinical applications and as research tools in both in vitro and in vivo studies (Katayose and Seth 1999; McConnell and Imperiale 2004) .
Recently oncolytic therapy with specially designed adenoviral vectors has emerged as a novel approach for the treatment of malignant diseases (Nettelbeck 2003; Wildner 2003; Dobbelstein 2004) . Advances in molecular biology and a better understanding of tumor biology have led to the design of genetically modified adenoviruses that replicate only in tumor cells (Conditionally replicating adenoviruses or CRAV) and are replication defective in normal tissue. Restricted replication of CRAV in malignant cells leads to the eventual lysis of the tumor cells without any detrimental effects on the surrounding tissue(s).
One of the CRAVs, 01/PEME, was developed based on the dysfunctional p53 pathway in many tumors (Ramachandra et al. 2001) . This virus carries a deletion in E1a that abolishes binding of E1A with the p53 transcriptional co-activator p300/CBP. It also expresses, driven by a p53-responsive promoter, an E2F-Rb fusion protein containing the DNA-binding domain of E2F and transrepression domain of Rb. Furthermore, it overexpresses E3-11.6K protein to enhance cell lysis. In normal cells with functional p53, 01/PEME expresses E2F-Rb that antagonizes the function of E2F to inhibit E1 expression and the entry to S phase. In tumor cells, however, the 01/ PEME replicates as efficiently as wild type virus (Ramachandra et al. 2001) .
The human lung carcinoma cell line A549 was chosen for the amplification of 01/PEME due to its defect in the p53 pathway (Ramachandra et al. 2001) . This cell line is normally propagated in adherent culture with medium containing serum. Scaling up of anchorage-dependent cells as a monolayer culture presents a major challenge during process development. Also, viral inoculation and harvesting of virus particles associated with the cell at the end of the production cycle could further complicate operation of a process with attached cells. The establishment of a suspension cell line is one of the choices to overcome these operational hurdles. In addition, removal of serum from the process reduces cost, increases product quality and consistency, and simplifies downstream processes.
In this report, we describe the adaptation of the A549 cell line into suspension culture by stepwise weaning from serum. The suspension-adapted A549 cells were continually propagated in an animal material-free medium. The production of the CRAV 01/PEME was demonstrated in small-scale research batches. Extended culturing of the A549 cells showed no apparent changes in growth or virus production, suggesting that the cell line is stable in suspension culture. Results from further process optimization and characterization of the A549 cells in suspension culture are also presented.
Materials and methods
Cell line and suspension adaptation A549 cells were originally obtained from ATCC (CCL-185) and cultured in DMEM medium (Biowittaker, Walkersville, MD) supplemented with 10% FBS (HyClone, Logan, UT). The attached A549 culture was adapted to serum-free suspension by cultivating the cells in sequential 1:1 dilutions of the serum-containing medium with the serum-free medium. Serum-free medium (denoted as A549-4-06) was prepared by supplementing IS 293-V (Irvine Scientific, Santa Ana, CA) with 0.1% pluronic F-68 (GIBCO, Grand Island, NY), 15 mM Tris pH 7.4 (Cambrex, Rockland, ME), 1 · Trace Elements A, B and C (Mediatech, Herndon, VA), 1 · FeNaEDTA (Irvine Scientific), 1:1000 dilution of Chemically Defined Lipid Concentrate (GIBCO) and 8 mM L-glutamine (GIBCO).The resulting medium mixtures contained 5, 2.5, 1.25 and 0.6% FBS, respectively. Cells were allowed to adapt at each serum level for 2 to 3 passages. The attached culture with 0.6% FBS was trypsinized and transferred into an Erlenmeyer flask with vent cap (Corning, Corning, NY). Serum weaning was then resumed in shake flasks until the growth rate stabilized. Shake flasks were agitated at 110 rpm on an orbital shaker (Model 4530, Forma) . All cell cultures were maintained in a 37°C tissue culture incubator supplied with 5% CO 2 . Cell banks were prepared and stored in liquid nitrogen with freezing media (80% IS 293-V, 10% DMSO (Sigma, St. Louis, MO) and 10% FBS).
Cell counting and culture monitoring
Cell counting and viability assessment were obtained by a combination of standard hemacytometer count with Trypan Blue dye exclusion and a Nicomp AccuSizer 780 Optical Particle Sizer (Particle Sizing Systems, Langhorne, PA) that measures cumulative volume of the cell aggregates for an estimation of total cell counts (Tsao et al. 2000) . Culture pH was measured offline by an ABL5 Blood-Gas Analyzer (Radiometer Medical A/S, Copenhagen Denmark). CRAV (01/PEME) production in bioreactors
The scale-up development of virus production was initiated in Braun Biostat 2 l Bioreactors, connected to a DCU3 control module and a gas mixer (1057-C) (B. Braun Biotech, Allentown PA). The bioreactors were fitted with an internal spin filter with a mesh size of 20 microns and equipped with a 3 inch pitch blade impeller (B. Braun Biotech). The culture temperature was maintained at 37°C with a heating blanket (B. Braun Biotech). Dissolved oxygen was maintained at 40% of air saturation by a single loop controller. The flow rate of air in the headspace was maintained at 0.1 l min )1 . The bioreactor tanks were inoculated with cells from shake flasks in A549-4-06 medium. The total working volume was 2 l. The agitation rate was maintained at 120 rpm during the subsequent cell growth and virus production. Perfusions with fresh A549-4-06 were performed during growth phase. Virus was inoculated at a final concentration of 1 · 10 8 vp ml )1 . Approximately 20 h post virus inoculation, another perfusion with 2 l of A549-4-06 medium was conducted. The pH was kept above 6.8 during the entire culture period with 1 M Na 2 CO 3 solution (Sigma).
Sample preparation and analysis of viral production Collected culture samples were subjected to three freeze/thaw cycles in a dry ice -ethanol bath and a 37°C water bath, followed by centrifugation at 3000 rpm for 20 min in a bench-top centrifuge (Model GS-6R, Beckman Hsu et al. 1988) , and a flourescein-conjugated antimouse antibody (Molecular Probes, Eugene, OR). All samples were examined by FACS using a FACS Calibur flow cytometer (Becton Dickinson).
Results

Adaptation of A549 cells to serum-free suspension culture
The original A549 cell line from ATCC was first propagated in adherent culture using DMEM supplemented with 10% FBS. When the cells were detached from surface and transferred into a shake flask containing this medium, large cell aggregates can be observed within a few hours after the seeding. Within a few passages, the culture can not be further propagated due to extensive cell clumping (Fig. 1a) . Similarly, when the detached A549 cells were transferred directly to suspension culture using the med-ium A549-4-06, cell clumps were again observed ( Fig. 1b) , although a peak representing single cells can also be detected (Fig. 1b, bottom) . However, the degree of cell aggregation is still too extensive to allow proper cell growth during continuous passaging or efficient virus infection. This suggests that medium optimization alone is not sufficient for culturing A549 cells as a suspension culture. We then took a different approach by selecting A549 that grew as single cells in A549-4-06. As described in Materials and Methods, serum was eliminated from the A549 culture by serial passaging of the cells in medium mixtures of A549-4-06 and DMEM (10% FBS) with step-wise decreasing amounts of serum. Starting with a 1:1 ratio, the volume ratio of A549-4-06 to DMEM (10% FBS) was doubled at each steps of serum weaning. These cells were eventually transferred into shake flasks when serum concentration reached~0.6% and were then continually passaged until sustained growth in a serum-free environment ( < 0.01% FBS) was achieved. During the entire course of adaptation, large cell clumps were removed by allowing them to settle down to the bottom of the shake flask. The resulting A549 suspension culture consisted of mostly single cells or small clumps with high viability (Fig. 1c) .
Production of 01/PEME in suspension adapted A549 cells Production of a CRAV, 01/PEME, from A549 cells in suspension culture was first evaluated in shake flasks. Previous results with E1-deleted recombinant adenoviral vectors in HEK293 cells indicated that medium exchanges (or feeds with fresh medium) at or during virus infection are essential for virus production (Garnier et al. 1994; Cote et al. 1998; Tsao et al. 2001) . We therefore evaluated the effect of different medium exchange procedures on 01/PEME production. A549 suspension cells were first allowed to reach 2.0 · 10 6 cell ml )1 in batch mode. The subsequent virus infection following growth phase were performed using four parallel procedures. First, the culture was maintained as batch culture; no medium exchange or fresh medium feed was performed. Second, a medium exchange was performed immediately prior to virus inoculation. Third, a medium exchange was performed approximately 20 h post viral inoculation. Fourth, two medium exchange operations were performed, one immediately prior to inoculation and one~20 h after inoculation. Cell culture samples were collected on a daily basis post infection for the measurement of virus particles produced. Data in Fig. 2 showed that both medium exchanges, pre-and post-infection, were required for the maximum volumetric productivity of 01/PEME in suspension A549 cells. We then evaluated the effect of virus concentration on 01/PEME production. Efficiency of infection is one of the possible limiting steps during the early stages of virus infectious cycle. Ideally, one would like to achieve synchronized infection of all production cells with the lowest amount of virus inoculum possible. In this experiment, A549 cells were cultured as described in Fig. 2 . Two medium exchanges were performed for virus infection, one immediately before infection and one~20 h post infection. The cultures were inoculated with increasing amounts of 01/PEME, from 0.125 to 8 · 10 8 vp ml )1 with a stepwise increment of 2 fold. Virus titer was assayed on a daily basis post infection. Results shown in Fig. 3 indicate a dose-dependent increase in volumetric virus production with inoculation concentration up to approximately 1 · 10 8 vp ml )1 . However, no significant differences were seen in virus titer when the viral inoculum concentration was greater than 1 · 10 8 vp ml )1 . Subsequent infection experiments with 01/PEME were, therefore, carried out with inoculation concentrations at 1 · 10 8 vp ml )1 .
Effect of calcium supplementation on 01/PEME production in A549 suspension culture
The main obstacles during adaptation and propagation of adherent cells in a suspension culture are the control of cell aggregation and the prevention of attachment to the vessel surface. Many cell surface molecules involved in cell-cell or cell-matrix interactions are calcium-dependent. To facilitate the adaptation and maintenance of cells in suspension culture, calcium concentration in a medium designed for suspension culture is often dramatically reduced compared to standard culture media for adherent cultures. However since calcium is critical for cell survival, the calcium concentration in suspension media usually represents a balance between control of cell aggregation/adhesion and optimized cell growth.
Although we demonstrated that the low calcium level (~108 lM) provided by A549-4-06 supports A549 cell growth with minimal cell clumping, it was unclear whether virus production is negatively affected by the relatively lower calcium concentration (Tsao et al. 2001) . To demonstrate the effect of calcium on 01/PEME production, increasing concentrations of calcium chloride were supplemented to the culture medium 2 h post infection. Results from this experiment showed a dose-response in virus production to the additional calcium (Fig. 4) . Volumetric production could be increased by approximately 30% with the addition of 1 mM or more of calcium chloride, with titer levels reaching 80-100 · 10 9 vp ml )1 . Time-course experiments with calcium chloride indicates that the effect on productivity is relatively insensitive to the timing of addition, since similar dose-response curves were obtained from 1 to 6 h post virus infection (data not shown). So, in order to maximize virus production by suspension cells, calcium levels must be increased. Production of 01/PEME in 2 l stirred tank bioreactors Difficulties in controlling and monitoring a shake flask in a tissue culture incubator limit the full exploration of the production potential of A549 cells.
To address this issue, we initiated process development in 2 l stirred tank bioreactors by simulating the baseline process established in shake flasks. In the experiment described in Fig. 5 , two bioreactor tanks were seeded with suspension A549 cells at two different seeding densities, 0.5 or 1.0 · 10 6 cells ml )1 , respectively. Perfusions with fresh A549-4-06 medium were performed with both tanks. Tank A seeded with 1.0 · 10 6 cells ml )1 were perfused twice during growth, while Tank B seeded with 0.5 · 10 6 cells ml )1 were perfused only once. Perfusion operations were performed on a continuous basis with one tank volume, i.e. 2 l of fresh A549-4-06. Immediately prior to viral inoculation, another perfusion was performed on both bioreactors. This was followed by another perfusion one day after infection. Volumetric virus titer was measured post infection and was in the range of 100-150 · 10 9 vp ml )1 (Fig. 5) . It is important to point out that although the maximum cell density reached with Tank A is consistently higher than that of Tank B, the volumetric yield is lower in Tank A. The apparent lower specific productivity on a per cell basis suggests that other factors may become limiting in Tank A compared to Tank B.
Stability of A549 cells adapted into suspension culture
A production host cell line must possess two characteristics with respect to stability in order to ensure a scalable process. First, the cell culture should demonstrate robust growth over extended passage. Second, there should not be a significant drop in productivity during the same period of time. Fig. 4 Effect of calcium addition post infection on CRAV 01/ PEME production by A549 cells. A549 cells grown in serumfree suspension culture were inoculated with CRAV 01/PEME at the concentration of 1 · 10 8 vp ml )1
. Calcium chloride was added to the culture 2 h post infection at the final concentrations indicated. Virus production on a volumetric or per cell basis was measured at day two post infection In most cases of genetically engineered cell lines, genetic stability can be sustained by the use of selection agents and the degree of stability can be determined by monitoring molecular and cellular markers. The stability of a naturally occurring cell line such as A549, however, could be less predictable and more difficult to control. To evaluate the stability of the suspension-adapted A549 cells, we monitored changes in their growth rate and virus production (Fig. 6) . Our data indicate that the A549 cells are ready to grow immediately after thawing, as shown in the first data point of the growth curve. This translates to about 40% cell growth per day (specific growth rate~0.014 h )1 ). This initial growth was followed by a gradual increase until reaching an apparent plateau at approximately generation 60. The increase in growth rate with passing is common among many cell lines when the culture is initiated from a cryogenically preserved condition. While the culture above was continuously cultured for determining growth rate, satellite cultures were split off and infected with the 01/PEME for evaluation of virus production. The maximum virus titer (typically in the range of 100-150 · 10 9 vp ml )1 )
was achieved approximately 48 h post infection in all cases. Virus productivity, both volumetric and specific productivity on a per cell basis (Fig. 6) indicates that A549 productivity in suspension culture can be maintained for more than 90 generations of cell divisions. Molecular characterization of suspension-adapted A549 cell for adenovirus production Productive infection of a host cell by an animal virus requires a series of highly organized virus-host interactions. The mechanisms governing the balance of the interactions are sensitive to environmental changes. Cells grown in suspension experience numerous mechanical stresses not present in static adherent cultures; therefore, adaptation to suspension growth may alter the pathways leading to virus infection and replication. To address this concern, experiments were performed to characterize infection of suspension A549 cells. Infection efficiency upon virus inoculation could conceivably be a rate-limiting step during virus infection. One sensitive and convenient way to monitor the infection kinetics is the utilization of an indicator virus carrying an easily detectable marker. We chose a replication defective (E1-minus) adenoviral vector carrying green florescent protein (GFP) to track the infected cell population (Wills et al. 1994 ). The lack of virus replication ensures that secondary infection does not take place as a result of virus release from the primary infection, allowing us to determine the infection efficiencies at the time of virus inoculation. Using this reporter virus, we observed no significant difference between the parental adherent cells and the suspension adapted cells with respect to the percent of cells infected, suggesting that the infection efficiency of the A549 cells is not significantly altered (Fig. 7) .
To further characterize the infectivity of suspension cells, we examined the cell surface expression of the coxsackievirus and adenovirus receptor (CAR). CAR is the key molecule that mediates the attachment of adenovirus to host cells (Bergelson et al. 1997; Cohen et al. 2001; Meier and Greber 2004; Zhang and Bergelson 2005) . The level of CAR expression can be affected by growth signals in the culture environment (Vincent et al. 2004) . FACS analysis showed that expression of CAR on the surface of suspension-adapted A549 cells is comparable to those seen prior to adaptation (Fig. 8) . This further supports the finding in Fig. 7 that mechanisms involved in early infection events were maintained during suspension-adaptation of A549 cells.
We have observed that human cell lines cultured in serum-free suspension culture tend to produce fewer adenoviral particles on a per cell basis than adherent cells (unpublished data). It was not clear, however, whether this is due to the genetic changes of the cells or to the differences in culture environment. To answer this question, we infected suspension-adapted cells in stationary culture dishes using DMEM containing 10%FBS, the medium used for attached culture. These cells showed no reduction in virus production in comparison with pre-adapted control A549 cells on a per cell basis (Fig. 9 ). This indicates that the apparent decrease in virus production is . FACS analysis was performed for GFP-positive cells post infection likely not due to molecular or genetic changes induced by adaptation into suspension. Further experiments will need to be performed to determine if the suspension environment plays a role.
Discussion
Suspension cell culture is often the choice for the production of biologics at large scale (Hu and Aunins 1997; Iyer et al. 1999; Chu and Robinson 2001) . Propagation of production host cells in an anchorageindependent manner is relatively simple during scaling up. Production in suspension culture also simplifies the downstream process and offers the potential to reduce production costs. More importantly, culturing cells in suspension mode provides an opportunity to reduce or eliminate animal-derived components and so will improve the safety profile of the final product. However, most production cell lines were originally derived from cells grown in adherent cultures. Adapting these adherent cells to suspension culture without serum supplements can in some cases be difficult. Previously, it was shown that A549 cells can be adapted to serum-free and growth factor-free conditions and be maintained for an extended period of time (Siegfried et al. 1994) . However, this experiment was carried out as a stationary culture instead of as a suspension culture. Long term propagation of A549 cells in suspension culture with mechanical agitation has not been reported. Recently, an A549 derived cell line was successfully adapted to serumfree suspension culture for the production of adeno-associated viral vectors (Farson et al. 2004) . However, the cell culture medium used in this report contains human serum albumin.
One of the major challenges in culturing originally adherent cells in suspension culture is to control cell aggregation. A549 cells prior to suspension-adaptation tend to form large clumps in DMEM medium or medium designed for the suspension culture of other human cell lines (Fig. 1a, b) . To overcome this problem, we took the approach of gradually weaning the serum from the culture medium. In addition, during the course of serum weaning, the degree of cell aggregation was monitored and large clumps Effect of suspension-adaptation on CRAV production. Suspension-adapted A549 cells were allowed to grow as an adherent culture in DMEM with 10% FBS for approximately 24 h before infection with CRAV 01/PEME. Cultures were harvested daily for virus production. To calculate virus productivity on a per cell basis, the maximum virus concentration reached at day 2 p.i and day 3 p.i., respectively and peak cell population reached at day 1 p.i. were used were removed from the cultures. The combination of gradual adaptation and population selection resulted in the full adaptation of the adherent A549 cells into suspension culture (Fig. 1c) . For the production of 01/PEME, a CRAV, a baseline process was first developed in shake flasks. Medium perfusion seems to be essential for virus production (Fig. 2) . It is not completely understood why medium exchange is required to achieve high productivity. We did not observe depletion of amino acids, glucose or glutamine and supplementation with amino acids and other nutrients alone cannot substitute for medium exchange. There is no sign of significant accumulation of lactate or ammonia (Ferreira et al. 2005) . Volumetric productivity reached a plateau when virus was inoculated at and higher than 1 · 10 8 vp ml )1 (Fig. 3) . Supplementation of calcium to the medium post infection increases the virus production in a dose-dependent manner (Fig. 4) . The baseline line process was repeated and virus production was confirmed in stirred tank bioreactors (Fig. 5) . To confirm the long term stability of the suspension-adapted A549 cells to allow scaleable production, the growth rate and productivity of the CRAV were measured at different in vitro cell ages (Fig. 6 ). Our data indicates that both growth and virus production are maintained during the course of extended passaging. Maintaining proper virus-host interactions in serum-free suspension culture is one of the keys for the optimization of a virus production process. We therefore compared attached and suspension-adapted A549 cells for different properties related to infection. Using a recombinant adenoviral vector expressing GFP, we have shown that the infection efficiency was comparable with the two cell populations, suggesting that the molecular events involved in the early stage of adenovirus infection were not significantly altered as the result of the suspension adaptation. In particular, CAR showed no significant changes in cell surface expression. Finally, the production potential measured on a per cell basis was not negatively impacted by the process of suspension adaptation (Fig. 9) . All evidence suggests that although the suspension adaptation may have resulted in subpopulation selection with respect to some properties, such as the degree of cell clumping, the cellular mechanisms involved in adenovirus replication were maintained.
In conclusion, we have successfully adapted the human lung carcinoma cell line A549 to growth in serum-free and animal material-free suspension culture. A baseline process for the production of CRAV was developed in shake flasks and then confirmed in stirred tank bioreactors. Although the robustness and stability of the cell line were shown to be sufficient for a scalable process, the requirement for medium perfusion could present a major challenge during large scale operation. A better understanding of virus-host interactions and further characterization of A549 physiology in suspension should lead to the development of a fed-batch process at manufacturing scale.
